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Herpes Simplex Virus type-1 
infection induces synaptic 
dysfunction in cultured cortical 
neurons via GSK-3 activation and 
intraneuronal amyloid-β protein 
accumulation
Roberto Piacentini1,*, Domenica Donatella Li Puma1,*, Cristian Ripoli1, Maria Elena 
Marcocci2, Giovanna De Chiara3, Enrico Garaci4, Anna Teresa Palamara2,4 & Claudio Grassi1,4
Increasing evidence suggests that recurrent Herpes Simplex Virus type 1 (HSV-1) infection spreading 
to the CNS is a risk factor for Alzheimer’s Disease (AD) but the underlying mechanisms have not been 
fully elucidated yet. Here we demonstrate that in cultured mouse cortical neurons HSV-1 induced 
Ca2+-dependent activation of glycogen synthase kinase (GSK)-3. This event was critical for the 
HSV-1-dependent phosphorylation of amyloid precursor protein (APP) at Thr668 and the following 
intraneuronal accumulation of amyloid-β protein (Aβ). HSV-1-infected neurons also exhibited: 
i) significantly reduced expression of the presynaptic proteins synapsin-1 and synaptophysin; ii) 
depressed synaptic transmission. These effects depended on GSK-3 activation and intraneuronal 
accumulation of Aβ. In fact, either the selective GSK-3 inhibitor, SB216763, or a specific antibody 
recognizing Aβ (4G8) significantly counteracted the effects induced by HSV-1 at the synaptic level. 
Moreover, in neurons derived from APP KO mice and infected with HSV-1 Aβ accumulation was 
not found and synaptic protein expression was only slightly reduced when compared to wild-type 
infected neurons. These data further support our contention that HSV-1 infections spreading to the 
CNS may contribute to AD phenotype.
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive decline in cogni-
tive functions leading to memory loss and dementia1. Among the numerous factors concurring to AD 
pathogenesis, infectious agents may play a key role. In particular, epidemiological and experimental 
evidence demonstrated a link between HSV-1 infection reactivation and AD (references in 2–4). We pre-
viously reported that HSV-1 binding to the plasma membrane of rat cortical neurons induces membrane 
depolarization due to activation of persistent Na+ currents and inhibition of “leak” K+ currents that, in 
turn, triggers intracellular Ca2+ signals leading to increased intracellular Ca2+ levels ([Ca2+]i)5. These sig-
nals trigger phosphorylation of threonine at position 668 (Thr668) of amyloid precursor protein (APP) 
as well as of the same amino acid residue in the C-terminus fragment of APP, named AID or AICD6,7.
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Following HSV-1-induced phosphorylation at Thr668, APP is subjected to multiple cleavages by secre-
tases (β and γ ) and caspases. As a consequence, several APP fragments (APPFs) including amyloid-β 
protein (Aβ ) are formed and they are released in the extracellular medium and accumulated intracel-
lularly5,8. It is known that Thr668 of APP and its C-terminus fragment are substrate for the glycogen 
synthase kinase (GSK)-3, as well as for several other kinases including c-Jun N-terminus kinase (JNK) 
and Cyclin-dependent kinase 5 (Cdk-5)9–12. GSK-3 is a Ser/Thr kinase composed of two isoforms (α 
and β ) that plays a central role in AD13. GSK-3 is markedly activated in the brains of AD mouse mod-
els14–15 and patients16. This activation, obtained by either increased phosphorylation at Tyr residues (279 
or 216 for α and β isoforms, respectively) or decreased phosphorylation at Ser sites (21α and 9β ), has 
been reported to mediate synaptic damage induced by Aβ 17. On the other hand, reduced activation of 
GSK-3β results in decreased APP processing and lower production and intracellular accumulation of 
Aβ 18. Intraneuronal Aβ accumulation causes numerous structural and functional synaptic alterations 
including reduced expression of presynaptic proteins, and impaired synaptic transmission and plas-
ticity19–24. Notably, function and structure of synapses also depend on GSK-3 activation17,25–27.
Although many papers including ours suggested the involvement of HSV-1 infection in AD patho-
genesis, data demonstrating the effects of HSV-1 on the synaptic function underlying learning and 
memory are still lacking. Here we report that HSV-1 infection markedly affects synaptic function via 
GSK-3-dependent intraneuronal accumulation of Aβ .
Results
Ca2+-mediated activation of GSK-3 induced by HSV-1 is critical for APP phosphorylation at 
Thr668. We previously demonstrated that HSV-1 infection induces Ca2+-dependent phosphorylation 
of APP at Thr668 (pAPP) in rat cortical neurons in vitro5. Immunoreactivity for pAPP was found on the 
membrane and in the nuclei of infected cells, thus suggesting that the antibody raised against pAPP also 
recognized the C-terminus fragment of APP, AICD, that accumulates in the nucleus and is phosphoryl-
ated at the same threonine residue6.
Given that APP is substrate for several kinases including GSK-3, JNK and Cdk-5, we studied their 
involvement in HSV-1-induced APP phosphorylation by adding specific kinase inhibitors to the cul-
ture medium of infected cells during the entire post-infection (p.i.) time. Twenty-four hours p.i. pAPP 
immunoreactivity was 1.85 ± 0.08 times larger than that found in mock-infected cells (n = 131 vs. 125, 
respectively; P = 1.3 × 10−57, assessed by Student’s t test; Fig. 1a,b,d,e,g). One way ANOVA revealed sta-
tistically significant differences after kinase inhibitor application (F4,413 = 10.2; P = 1.1 × 10−11). In par-
ticular, the ATP-competitive GSK-3 inhibitor, SB216763 (10 μ M; Tocris, Minneapolis, MN) reduced the 
HSV-1-induced increment in pAPP immunoreactivity by 54% (from 1.85 ± 0.08 to 0.86 ± 0.10; n = 65; 
P = 9.9 × 10−15 vs. HSV-1 with no inhibitors, assessed by Bonferroni post-hoc test; Fig. 1c,f,g). Western 
blot data confirmed these results (Fig. 1h,i). The inhibitor of Cdk-5, roscovitine (10 μ M, Sigma; St. Louis, 
MO) reduced the HSV-1-dependent increase in pAPP by 39% (from 1.85 ± 0.08 to 1.12 ± 0.11; n = 40; 
P = 3.9 × 10−7 vs. HSV-1 alone; Fig. 1g) whereas the JNK inhibitor “I” (5 μ M, Merck Millipore, Billerica, 
MA) had a slight but not significant effect (the fluorescence increase was 1.49 ± 0.12; n = 56; P = 0.49 
vs. HSV-1 alone; Fig.  1g). When SB216763 and roscovitine were applied together HSV-1 failed to sig-
nificantly increase pAPP immunoreactivity (P = 6.5 × 10−2, Student’s t test, mock vs. HSV-1+ inhibitors; 
n = 125 and 126, respectively; Fig. 1g). These data suggest that both GSK-3 and Cdk-5 are involved in 
the HSV-1-induced phosphorylation of APP, with the former playing a prominent role.
Therefore, we further investigated the effects of HSV-1 on GSK-3 activation by studying its phos-
phorylation at Tyr279 and 216 (pGSK-3) that are well known activatory sites for α and β isoforms of 
this kinase, respectively. At 18 h p.i. pGSK-3 immunoreactivity was 1.25 ± 0.07 times greater than that 
of mock-infected neurons (n = 71 and 244, respectively; P = 1.3 × 10−71, Student’s t test; Fig.  2a,b,d). 
This effect, that preceded the marked increase in APP phosphorylation we observed at 24 h p.i., was 
counteracted by SB216763 (10 μ M), thus confirming the specificity of pGSK-3 immunostaining (data 
not shown).
In previous studies, we demonstrated that HSV-1 binding to the cell membrane triggered intra-
cellular Ca2+ signals producing APP phosphorylation at Thr6685. These Ca2+ transients depended on 
both Ca2+ entry through Cav1 channels and Ca2+ release from intracellular stores, eventually leading 
to [Ca2+]i increases5. Based on these findings, we asked whether Ca2+ signals regulate GSK-3 phospho-
rylation at Tyr279/216 upstream APP phosphorylation. In the presence of the intracellular Ca2+ chela-
tor BAPTA-AM (1 μ M, Sigma), the HSV-1-induced increase in pGSK-3 immunoreactivity was reduced 
by 80% at 18 h p.i. (from 1.25 ± 0.07 to 0.25 ± 0.07; n = 40, P = 2.3 × 10−7 vs. HSV-1, Student’s t test ; 
Fig. 2c,d) thus indicating that intracellular Ca2+ dyshomeostasis triggered by HSV-1 is involved in the 
Tyr-dependent activation of GSK-3.
Given that many studies pointed out the importance of the GSK-3β isoform in mediating the action 
of this kinase, we performed Western blot experiments to determine if GSK-3β was activated follow-
ing HSV-1 infection. Notably, we found a marked increase of pGSK-3β in HSV-1-infected neurons 
(Fig. 2g,h) whereas the total expression of GSK-3β was not significantly modified, as also demonstrated 
by immunofluorescence (total GSK-3 immunoreactivity was: 1.00 ± 0.06 and 1.09 ± 0.07 in mock and 
HSV-1-infected cells, n = 22 and 28 respectively; P = 0.07 Student’s t test; Fig.  2e–h). Finally, to deter-
mine whether the observed effects depended on HSV-1 binding to the cell membrane, we repeated 
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Western blot experiments in cells treated with UV-inactivated HSV-1 that retains the ability to bind 
the membrane and activate the signaling cascade leading to increased [Ca2+]i but it does not replicate 
inside cells. No significant increases in pGSK-3β /GSK-3β ratio were induced by UV-inactivated HSV-1 
(P = 0.10 vs. mock; Fig. 2g,h).
In agreement with our recent findings in rat cortical neurons28 and other literature reports29,30, HSV-1 
infection also slightly increased GSK phosphorylation at Ser9 (Suppl. Fig. 1). However, the effect of the 
GSK-3 inhibitor SB216763 on APP phosphorylation suggests that the “net” result of HSV-1-induced 
GSK-3 phosphorylation is the kinase activation.
GSK-3 activation mediates intraneuronal accumulation of Aβ. We previously demonstrated that 
the culture medium of HSV-1-infected neurons contained small soluble Aβ oligomers (i.e., dimers and 
trimers), and lysates of infected neuronal cells subjected to Western blotting exhibited a band recog-
nized by the 4G8 antibody (that specifically reacts with murine high molecular weight Aβ aggregates) at 
35 kDa, likely corresponding to a Aβ nonamer5,8. Here we showed that mouse cortical neurons infected 
with HSV-1 exhibited an increased immunoreactivity for Aβ 40/42 with respect to mock-infected cells 
Figure 1. HSV-1-induced APP phosphorylation at Thr668 depends on GSK-3 and Cdk-5 activation. 
(a,b,d,e) Representative examples of pAPPT668 immunoreactivity (green) in mock- and HSV-1-infected 
neurons at 24 h p.i., respectively. Phosphorylation of APP markedly increased in HSV-1-treated neurons. (c,f) 
The presence of the selective GSK-3 inhibitor SB216763 (10 μ M) in the culture medium significantly reduced 
(− 54%) the increase in pAPP immunoreactivity observed in HSV-1-infected neurons. Red staining indicates 
HSV-1 and MAP2 immunoreactivity in (a–f), respectively. (g) Bar graphs showing mean pAPP fluorescence 
intensity in the conditions represented in a-c (mock, HSV-1 and HSV-1+ SB216763) and in HSV-1-infected 
cells in the presence of inhibitors of JNK and Cdk-5 (JNK inhibitor I and roscovitine, respectively). 
Combination of SB216763 and roscovitine prevented the effects of HSV-1 on pAPP immunoreactivity. (h) 
Western blot analysis of pAPPT668, APP and GAPDH carried out on lysates of mock-infected cells, HSV-
1-infected cells at 24 h p.i., and infected cells treated with the specific inhibitor of GSK-3 SB216763 for all 
the time p.i. (i) Densitometric analysis of three independent Western blot experiments. Scale bar: 20 μ m 
in panels (a–c) and 50 μ m in panels (d-f). *P < 0.05 vs. mock; **P < 0.001 vs. mock; #P < 0.05 vs. HSV-1; 
##P < 0.001 vs. HSV-1. In this, and the following figures, statistical significance was assessed by Student’s t 
test for comparison between mock and HSV-1, and by one-way ANOVA with Bonferroni post-hoc test for 
multiple comparisons. For experiments that included fewer than 10 observations (e.g. densitometric analysis 
of WB data), the Mann-Whitney (Wilcoxon) statistic was used.
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(Fig. 3a,b,d,e). We then specifically looked for intracellular accumulation of Aβ 42 in infected neurons, 
that was assessed by an antibody recognizing the C-terminus region of the protein (Fig. 3g,h). In agree-
ment with our previous reports, the specificity of Aβ 42 C-t immunolabeling was assessed by adding 
β - and γ -secretase inhibitors to the culture medium during the time p.i.5,8. Under these experimental 
conditions Aβ 42 C-t immunoreactivity was significantly reduced (data not shown).
Here we found that inhibition of GSK-3 activity by SB216763 significantly reduced Aβ fluorescence 
intensity in HSV-1-immunoreactive neurons. In fact, the increase in 4G8 immunoreactivity was com-
pletely abolished (P = 7.2 × 10−12; Student’s t test; n = 40 for HSV-1 and n = 38 for HSV-1+ SB216763; 
Fig.  3b,c,j) whereas immunolabeling with the Aβ 42 C-t antibody was reduced by 23% of untreated 
infected neurons (P = 2.8 × 10−4, Student’s t test; n = 43 for both mock and HSV-1-infected cells; 
Fig. 3h,i,l). These data indicate that HSV-1-induced Aβ production and accumulation depend on GSK-3 
activation. Western blot experiments confirmed these data on the band recognized by 4G8 at 35 kDa in 
lysates from infected cells (Fig. 3k).
Notably, cell treatment with SB216763 added after virus adsorption did not affect HSV-1 infection 
(viral titer: 6.4 × 103 vs. 5.4 × 103 pfu/mL without inhibitor, at 24 h p.i.).
Expression of the presynaptic proteins synaptophysin and synapsin-1 is affected by HSV-1 
infection. It is known that intracellular Aβ accumulation affects synaptic function21,23,24. Functional 
and structural alterations of synapses may also depend on GSK-3 activation17,25,27. Therefore, we inves-
tigated the effects of HSV-1 infection on: i) the expression of the presynaptic proteins synapsin-1 and 
synaptophysin; and ii) synaptic transmission in vitro, to subsequently determine the role of GSK-3 acti-
vation and Aβ accumulation in these effects. Twenty-four h p.i. we found a significant reduction in the 
expression of both proteins: − 58% respect to mock-infected neurons for synapsin-1 (n = 14 and 12 
fields, P = 1.5 × 10−3, Student’s t test; Fig. 4a,b,i); − 39% for synaptophysin (n = 21 and 19 microscopic 
fields [at 63 ×  magnification] analyzed for mock- and HSV-1-infected cells, respectively; P = 1.5 × 10−7, 
Student’s t test; Fig. 4e,f,i). These effects were clearly due to HSV-1 infection. In fact, when neuronal cul-
tures were treated with UV-inactivated virus no alterations in protein expression were observed at 24 h 
p.i. (n = 18 and 16 fields analyzed, P = 0.99 vs. uninfected cells, Student’s t test). The effects of HSV-1 
infection on presynaptic proteins clearly depended on GSK-3 activation and Aβ accumulation (one-way 
ANOVA: F2,35 = 10.3, P = 2.9 × 10−4 for synaptophysin and F2,37 = 9.0, P = 6.5 × 10−4 for synapsin-1). In 
Figure 2. HSV-1 induces Ca2+-dependent activation of GSK-3. (a–c) Representative examples of MAP2+ 
neurons (red) immunoreactive for GSK-3α /β phosphorylated at Tyr279/216 (pGSK-3; green), in mock- (a), 
HSV-1-infected neurons at 18 h p.i. (b), and infected neurons exposed to the intracellular Ca2+ chelator 
BAPTA-AM (1 μ M) for all the time p.i. (c). HSV-1 immunoreactivity (magenta) is shown in the dotted boxes 
inside the panels. The presence of BAPTA-AM (1 μ M) significantly reduced the effects of HSV-1 on pGSK-3 
immunoreactivity. (d) Bar graphs showing the mean pGSK-3 fluorescence intensity in the conditions 
represented in (a–c). (e,f) Representative examples of mock- and HSV-1-infected neurons immunostained 
for GSK-3 (green) and HSV-1 (magenta) at 18 h p.i. No significant changes were observed. (g) Western 
blot analysis of pGSK-3β Y216, total GSK and GAPDH carried out on lysates of mock-infected cells, HSV-
1-infected cells at 18 h p.i., and cells challenged for 1 h with UV-inactivated HSV-1 and then cultured for 
further 18 hours. (h) Densitometric analysis of three independent Western blot experiments. Scale bars: 
50 μ m. **P < 0.001.
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fact, when neurons were treated with the GSK-3 inhibitor SB216763 (10 μ M) the inhibitory effects of 
HSV-1 on synapsin-1 expression were significantly smaller than in infected, untreated neurons and the 
effects on synaptophysin expression were almost completely abolished. In particular, synapsin-1 den-
sity increased from 0.42 ± 0.10 to 0.68 ± 0.6 (n = 14 fields analyzed, P = 1.8 × 10−3, Bonferroni post-hoc 
test; Fig.  4b,c,i), whereas synaptophysin density increased from 0.61 ± 0.04 to 0.95 ± 0.12, with the 
mock-infected condition set at 1 (n = 10, P = 2.0 × 10−3, Bonferroni post-hoc test; Fig. 4f,g,i).
In agreement with previous reports31, addition of the GSK-3 inhibitor to the culture medium of 
mock-infected neurons significantly increased the expression of synapsin-1 (+ 36% of mock-infected 
neurons without SB216763; n = 13 microscopic fields; P = 7.3 × 10−3; Student’s t test), but it did not affect 
synaptophysin expression (n = 12 microscopic fields; P = 0.67; Student’s t test).
Figure 3. GSK-3 activation is involved in HSV-1-induced Aβ production and accumulation. Representative 
examples of mock-infected, HSV-1-infected and HSV-1-infected cortical neurons in the presence of SB216763, 
immunostained for HSV-1 and 4G8 (a–c), or a specific antibody against Aβ 40/42 (d–f). (g–i) Representative 
examples of cortical neurons in the same conditions shown in (a–f) immunostained with antibodies specifically 
recognizig Aβ 42 C-terminus and HSV-1. Arrow heads indicate Aβ accumulation. DAPI was used to label cell 
nuclei. (j,l) Bar graphs quantifying 4G8 and Aβ 42 C-t immunoreactivity in HSV-1-positive neurons under the 
conditions shown in (a–c) and (g–i), respectively. (k) Western blot analysis performed using 4G8 antibody on 
lysates of mock-infected cells, HSV-1-infected cells at 24 h p.i. in the presence or not of SB216763, and mock-
infected APP KO cells that were used as negative control. Black arrow head indicates a band at molecular 
weight of about 35 kDa. Scale bars: 20 μ m in panels (a–c); 10 μ m in panels d-f and 50 μ m for panels (g–i). 
**P < 0.001.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:15444 | DOi: 10.1038/srep15444
Finally, we determined if the intracellular Aβ accumulation that we observed following infection was 
involved in the GSK-3-dependent reduction of synaptic protein expression. To address this issue, we 
exposed neuronal cultures to 4G8 antibody (3.3 μ g/mL) during the post-infection period. It is known 
that extracellularly-applied 4G8 interacts with the extracellular site of APP, it is internalized and accumu-
lated intracellularly20. Once inside neurons, 4G8 antibody may bind Aβ and counteract its effects. In our 
experimental conditions, extracellular 4G8 was indeed internalized and it recognized HSV-1-produced 
Aβ (Fig. 5a–c). We found that the expression of synapsin-1 and synaptophysin in HSV-1-infected neu-
rons (24 h p.i.) exposed to 4G8 was significantly different from that of HSV-1-infected cells. In the pres-
ence of 4G8 the reduction of synapsin-1 and synaptophysin immunoreactivity passed from − 58% to 
− 33% and from –39% to –5%, respectively (P = 3.3 × 10−3 and P = 3.2 × 10−3, respectively vs. HSV-1; 
Bonferroni post-hoc test; Fig. 4d,h,i). These findings were supported by results of Western blot analyses 
(Fig. 4j,k).
To further investigate the dependence of the HSV-1-induced synaptic effects on APPF production, 
we infected cortical neurons isolated from APP-KO mice. Given that these cells do not express APP, 
HSV-1 failed to produce intracellular accumulation of Aβ 42 (compare Fig.  5d with Fig.  3h) although 
APP-KO neurons exhibited a clear HSV-1-induced activation of GSK-3 (Fig. 5e,f). When the immuno-
labeling of synaptophysin and synapsin-1 was evaluated in APP-KO-infected neurons, we found slight 
but not significant differences respect to APP-KO-mock-infected cells (for synapsin-1: P = 0.12, Student’s 
t test; n = 13 and 11 fields analyzed for mock and HSV-1-infected cells, respectively, Fig. 5h,i,g; for syn-
aptophysin: P = 0.12, Student’s t test; n = 9 and 14 fields analyzed for mock and HSV-1-infected cells, 
Figure 4. HSV-1 infection induces Aβ- and GSK-3-dependent reduction of synaptic protein expression. 
Mouse cortical neurons (DIV 15) were infected with HSV-1 in the presence or not of either SB216763 
(10 μ M) or 4G8 antibody (3.3 μ g/mL). (a–h) show representative examples of mouse cortical neurons 
immunostained for synapsin-1, MAP2 and HSV-1 or synaptophysin, MAP2 and HSV-1, respectively, at 24 h 
p.i. (i) Bar graphs quantifying synapsin-1 and synaptophysin density (see methods). (j) Western blot analysis 
of synapsin-1 and synaptophysin performed on lysates of mock-infected cells, HSV-1-infected cells at 24 h 
p.i., and cells treated with SB216763 or 4G8 antibody. GAPDH and tubulin were used as loading control for 
synapsin-1 and synaptophysin respectively. (k) Densitometric analysis of three independent Western blot 
experiments. Scale bars: 10 μ m and 30 μ m for panels (a–h), respectively. *P < 0.001 vs. mock; #P < 0.005 vs. 
HSV-1.
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respectively, Fig. 5j,k,g), thus supporting our contention that HSV-1-induced Aβ accumulation is respon-
sible for synaptic protein downregulation.
Synaptic transmission is affected by HSV-1 infection. We then evaluated whether the molec-
ular alterations induced by HSV-1 at the presynaptic level impaired synaptic transmission. To address 
this issue we studied the amplitude of evoked excitatory post-synaptic currents (EPSCs) and the ampli-
tude and the frequency of spontaneous miniature EPSCs (mEPCS). When autaptic cultures of mouse 
cortical neurons23,24 were infected with HSV-1 for 24 hours, EPSC amplitude was significantly reduced 
if compared to that of mock-infected neurons (− 36%; n = 10 and 19 for mock- and HSV-1-infected 
neurons, respectively; P = 1.7 × 10−3; Student’s t test; Fig.  6a,b). The same treatment also markedly 
reduced the frequency of mEPSC (− 49% vs. mock-infected neurons; n = 10 for mock and 18 for HSV-
1-infected neurons; P = 6.0 × 10−4; Student’s t test; Fig.  6c,d), whereas their mean amplitude was only 
slightly reduced (− 15% vs. mock infected neurons, P = 0.15; Fig.  6d). The inhibitory effects of HSV-1 
on both EPSC amplitude and mEPCS frequency were significantly reversed by the presence of 10 μ M 
SB216763 in the culture medium, and they depended on Aβ accumulation. Indeed, according to what 
Figure 5. Extracellularly applied 4G8 antibody is internalized in wild-type infected neurons and 
recognizes Aβ produced following infection whereas HSV-1-infected APP KO cortical neurons exhibits 
neither Aβ42 accumulation nor reduction of synaptic proteins. (a–c) Representative examples of 4G8 
antibody internalization in neurons infected with HSV-1 for 24 hours. 4G8 antibody was added to the 
culture medium for all the time p.i. and, after its internalization, it recognized intracellular Aβ produced 
following HSV-1 infection. 4G8 was revealed with secondary antibody after fixation and permeabilization 
of 4G8-treated cells at 24 h p.i. High magnification image of cell boxed in panel c shows that 4G8 
immunostaining was localized outer the nuclei of infected (HSV-1-positive) cells. Cell nuclei were stained 
with DAPI and are displayed in blue. (d) Representative example of HSV-1-infected APP-KO mouse cortical 
neurons and astrocytes at 24 h p.i. immunostained for Aβ 42, HSV-1 and DAPI. No Aβ 42 immunoreactivity 
was observed. (e,f) Infected APP-KO neurons (MAP2+, red) exhibited marked increase in pGSK-3 staining 
(green). (g) Bar graph quantifying synapsin-1 (red) and synaptophysin (white) densities in the conditions 
represented in (h–k). (h–k) Representative examples of synapsin-1 and synaptophysin staining of mock- and 
HSV-1-infected APP-KO cortical neurons (DIV 15) at 24 h p.i. Scale bars: 20 μ m for panels (a–f); 30 μ m for 
panels (h–k).
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we observed for presynaptic protein expression, 4G8 rescued synaptic transmission from the inhibitory 
effects of HSV-1. In particular, no significant differences were found between EPSC amplitudes recorded 
in mock-infected neurons and in neurons infected with HSV-1 and treated with either SB216763 or 4G8 
for all the time p.i. (one way ANOVA: F2,28 = 0.83, P = 0.44; Fig. 6a,b). Similar results were found for the 
mEPSCs frequency that was increased from 3.7 Hz in HSV-1-infected neurons to 6.7 Hz (n = 12) in the 
presence of the GSK-3 inhibitor and to 6.0 Hz (n = 10) in the presence of 4G8 antibody (P = 2.6 × 10−3 
and P = 3.6 × 10−2, respectively; Bonferroni post-hoc test; Fig. 6c,d).
HSV-1 inhibits CREB via GSK-3 and Aβ. Having demonstrated that HSV-1 infection induces 
GSK-3 activation and Aβ accumulation, we looked for downstream components of the HSV-1-triggered 
molecular pathway likely responsible for the synaptic dysfunction we observed. Among the numerous 
potential candidates, we focused on the cAMP response element-binding protein (CREB) because it is 
a critical determinant of synaptic function, it is target of Aβ and GSK-3β activation has been suggested 
to inhibit the CREB-mediated transcriptional program17,32. First, we determined whether CREB activ-
ity was modulated by HSV-1. CREB has two mutually exclusive phosphorylation sites that regulate its 
activity: Ser133 (activatory) and Ser129 (inhibitory), the latter being phosphorylated by GSK-333,34. We 
found that in HSV-1-infected neurons (24 h p.i.) pCREBS129 immunoreactivity was significantly increased 
with respect to mock-infected neurons (+ 35%; n = 88 and 92, respectively; P = 5.5 × 10−10, Student’s 
t test; Fig. 7a,b,i). On the contrary, fluorescence intensity for pCREBS133 was reduced by − 27% (n = 79 
and 82; P = 6.3 × 10−17, Student’s t test; Fig. 7e,f,i). Application of either SB216763 or 4G8 significantly 
reversed the effects of HSV-1 on CREB phosphorylation (one-way ANOVA; for pCREBS129: F2,191 = 32.1; 
P = 2.0 × 10−11; for pCREBS133: F2,223 = 65.4, P = 1.7 × 10−11). In particular, when SB216763 was present 
Figure 6. HSV-1 infection impairs synaptic transmission. (a) Representative examples of evoked excitatory 
post-synaptic currents (EPSCs) recorded in mock- and HSV-1-infected (24 h p.i.) autaptic neurons cultured 
with or without either SB216763 (10 μ M) or 4G8 (3.3 μ g/mL). (b) Bar graph quantifying the amplitude of 
EPSCs under the above described conditions. (c) Representative examples of spontaneous activity (miniature 
excitatory post-synaptic currents, mEPSCs) recorded in autaptic neurons infected or not with HSV-1 (24 h 
p.i.) and cultured with or without either SB216763 or 4G8. (d) Bar graph showing the mean frequency (left) 
and amplitude (right) of mEPSCs. *P < 0.005 vs. mock; #P < 0.05 vs. HSV-1.
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in the culture medium of infected cells the immunoreactivity of pCREBS129 and pCREBS133 was restored 
to values similar to those observed in mock-infected cells (P = 4.4 × 10−11 and 3.0 × 10−15 vs. HSV-1 
alone, Bonferroni post-hoc test, n = 54 and n = 64, for S129 and S133, respectively; Fig. 7c,g,i). Similar 
results were obtained with 4G8 (P = 3.0 × 10−8 and 4.6 × 10−12 vs. HSV-1 alone, Bonferroni post-hoc, 
n = 52 and n = 80, for S129 and S133, respectively; Fig. 7d,h,i).
Interestingly, application of SB216763 to mock-infected cells exerted a much smaller effect on CREB 
phorsphorylation. Indeed, immunoreactivities for pCREBS129 and pCREBS133 were modified by less than 
10% by inhibition of GSK-3 activity (+ 9%; P = 2.9 × 10−2 for S129 and –9% P = 1.4 × 10−3, for S133, 
n = 104 and 53, respectively), thus suggesting that this kinase plays a critical role in CREB activity espe-
cially following infection.
Discussion
In this study we demonstrated that HSV-1 infection impairs synaptic function in cultured mouse cortical 
neurons through GSK-3 activation and intracellular accumulation of Aβ . These events were responsible 
for the HSV-1-induced molecular and functional alterations we observed at the synaptic level consisting 
of: i) reduced expression of the presynaptic proteins synapsin-1 and synaptophysin; ii) depressed synaptic 
transmission. Finally, we found that Aβ - and GSK-3-mediated inhibition of CREB is likely involved in 
the HSV-1-induced synaptic effects.
In a previous report we demonstrated that HSV-1 binding to neuronal membrane of rat cortical 
neurons in vitro induces membrane depolarization due to activation of persistent Na+ currents and 
inhibition of leak K+ currents that, in turn, triggers intracellular Ca2+ signals (due to both Ca2+ entry 
Figure 7. HSV-1 inhibits the transcription factor CREB via GSK-3 and Aβ. (a–d) Representative images 
of mock- and HSV-1-infected neurons at 24 h p.i. cultured with or without either SB216763 (10 μ M) or 4G8 
(3.3 μ g/mL) and immunostained for pCREBS129 and MAP2. (e–h) Representative images of neurons cultured 
in the same conditions of (a–d) and immunostained for pCREBS133 and MAP2. (i) Bar graphs showing 
mean fluorescence intensities of CREB phosphorylation at Ser129 and Ser133, in the conditions represented 
in (a–h). Notably, the presence of SB261763 or 4G8 strongly counteracted the effect of HSV-1 on CREB 
phosphorylations. Scale bars: 30 μ m. **P < 0.001 vs. mock; ##P < 0.001 vs. HSV-1.
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through Cav1 channels and Ca2+ release from IP3 receptors) leading to increased [Ca2+]i5. Ca2+ transients 
triggered by HSV-1 binding to the membrane were responsible for APP phosphorylation at Thr668 as 
well as for phosphorylation of the same amino acid in the C-terminus region of APP, named AID or 
AICD7. The former is believed to be a key event in APP processing and Aβ production10,35, whereas the 
latter enables AICD to interact with the Fe65 adapter protein36 and enter the nucleus, where it affects 
gene transcription and induces neurodegeneration6,37. Very recently, we also demonstrated that the HSV-
1-induced nuclear accumulation of ACID regulates the expression of the Aβ clearance/degrading enzyme 
neprilysin and GSK-328. Here we found that HSV-1 infection induces an intense activation of GSK-3, as 
revealed by immunoreactivity for phospho-GSK-3α /β (at Tyr279/216). Western blot experiments also 
indicated that after viral infection GSK-3β phosphorylation at Tyr216 was significantly increased whereas 
the total amount of the protein did not significantly change, thus suggesting the specific activation of 
this kinase rather than upregulation of its expression following infection. HSV-1 infection also slightly 
increased Ser9 phosphorylation in mouse cortical neurons. In cultured human fibroblasts Naghavi and 
colleagues demonstrated that the viral Ser/Thr kinase Us3 inhibits GSK-3β activity by increasing its 
phosphorylation at Ser929. However, in our experimental model, the “net” resulting activity of GSK-3 
following 18–24 h of infection was increased. Indeed, the specific GSK-3 inhibitor, SB216763, reduced the 
HSV-1-induced increase in pAPP immunoreactivity by more than 50%. SB216763 has been reported to 
inhibit GSK-3 by specifically reducing pTyr279/216 rather than increasing pSer21/938. Our experiments 
performed with the intracellular Ca2+ chelator BAPTA-AM indicate that intracellular Ca2+ increases 
observed several h p.i. are involved in GSK-3 activation and the subsequent phosphorylation of APP and 
AICD we observed. These results are in line with those of Hartigan and Johnson39 demonstrating that, in 
response to transient [Ca2+]i increases induced by the ionophore A23187, GSK-3β activity was enhanced 
because of Tyr216 phosphorylation. Pierrot et al.10 also demonstrated that under depolarizing conditions 
GSK-3β phosphorylation at Try216 was increased in rat cortical neurons.
Our data also indicate that GSK-3 is involved in the HSV-1-induced production and intracellular 
accumulation of APPFs including Aβ 40 and 42. Indeed, neuronal immunostainings with either anti-
bodies labeling all APPFs containing the Aβ sequence 17–24 (i.e., anti-Aβ 40/42 and 4G8) or the Aβ 42 
C-terminus antibody, were significantly reduced in HSV-1-infected cells treated with SB216763 during 
the p.i. period, and similar results were also obtained with Western blot experiments. The involvement of 
GSK-3 in Aβ production is fully supported by previous literature reports showing that in vitro: i) GSK-3 
interacts with presenilins15; ii) GSK-3β promotes the production and intracellular accumulation of Aβ by 
enhancing pAPP10 as well as β -secretase activity40. Conflicting results have been reported in vivo where 
neither GSK-3α nor GSK-3β were found to modulate APP processing41, and GSK-3 inhibition reduced 
Aβ levels independently of APP processing modulation by acting on Aβ degradation/sequestration42.
Our findings provide novel evidence that HSV-1 infection affects synaptic function. To our knowl-
edge this is the first paper documenting that in HSV-1-infected neurons there is a GSK-3/Aβ -dependent 
decrease in the expression of presynaptic proteins that is associated with depressed synaptic transmission.
The role of intracellular Aβ accumulation in synaptic function dysregulation underlying cognitive 
impairment is well known19–24. Here we demonstrated that using two different approaches counteract-
ing or preventing HSV-1-induced Aβ production and accumulation (i.e., intracellular loading of 4G8 
antibody and APP KO mice, respectively), HSV-1 lost its synaptotoxicity. The residual effects of HSV-1 
that we found at the synaptic level under these experimental conditions might depend on several fac-
tors. First, 4G8 might be unable to fully counteract the APPFs produced following HSV-1 infection. In 
fact, Tampellini et al.20 showed that 24-h lasting 4G8 treatment of primary neurons from Tg2576 mice 
reduced intracellular Aβ levels by 30–40% only. We also found a slight reduction of presynaptic protein 
expression in HSV-1-infected APP null neurons. These findings allow us to speculate that other GSK-
3-dependent and Aβ -independent mechanisms compromising synaptic function might play a minor role 
in HSV-1 effects. Increased GSK-3 expression has been shown to negatively modulate neurotransmitter 
release via phosphorylation of VGCCs43, and GSK-3 inhibition has been found to increase neurotrans-
mission44 and synapsin-1 expression31. GSK-3 has been also found to be involved in the modulation of 
other ion channels including voltage-gated Na+ channels that may influence neuronal firing and synap-
tic transmission45–49. Moreover, GSK-3 up-regulation has been reported to impair synaptic plasticity at 
both functional and structural levels by reducing synapsin-1 clustering50 and dendritic spine density17, 
whereas GSK-3 inhibition by SB216763 or TDZD-8 reverted these effects. Finally, another possibility is 
that activated GSK-3 causes synaptic dysfunctions via Tau protein hyperphosphorylation51–53. All these 
data are in agreement with our finding that HSV-1 acts upstream GSK-3 activation and Aβ production. 
Aβ -independent effects due to virus binding to neuronal membrane did not play a role in the observed 
alterations of synaptic proteins. In fact, when neurons were infected with UV-pretreated virus retaining 
the ability to bind cell membrane but not that of replicating inside cells, no changes in synaptic protein 
expression were observed.
Our data also suggest that CREB is critically involved in the HSV-1-activated molecular pathway 
leading to synaptic dysfunction. CREB is a transcription factor whose activity is modulated by GSK-3β 
via phosphorylation at Ser12933,34,54. It also plays a pivotal role in structural and functional synaptic 
plasticity17,55,56. Here we found that CREB is inactivated following HSV-1 infection and that this inhi-
bition depends on GSK-3 activation and Aβ accumulation. These findings allow us to hypothesize 
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that GSK-3-induced CREB inhibition is a critical determinant of HSV-1-induced synaptic dysfunction 
although further studies are needed to gain in-depth understanding of its role in the observed effects.
Collectively, findings reported here suggest that HSV-1 alters the expression of synaptic proteins via 
activation of GSK-3 and intraneuronal accumulation of Aβ . Although the production and accumula-
tion of Aβ has been reported in the temporal brain cortex of mice 5 days after intranasal inoculation 
with HSV-157, further studies on wild-type and AD transgenic mice are needed to demonstrate the 
cause-and-effect relationships among recurrent HSV-1 infections, Aβ overproduction and synaptic dys-
function underlying cognitive impairment in AD.
Material and Methods
Primary cortical neuron cultures. Primary cultures of cortical neurons were obtained from E18 C57/
bl6 mice and B6.129S7-Apptm1Dbo/J mice as previously described5. Briefly, after removing brains, dis-
sected cortices were incubated for 10 min at 37 °C in PBS containing trypsin-ethylenediaminetetraacetic 
acid (0.025%/0.01% w/v; Biochrom AG, Berlin, Germany), and the tissue was mechanically dissoci-
ated at room temperature (RT) with a fire-polished Pasteur pipette. The cell suspension was harvested 
and centrifuged at 235 × g for 8 min. The pellet was suspended in 88.8% Minimum Essential Medium 
(MEM, Biochrom), 5% fetal bovine serum, 5% horse serum, 1% glutamine (2 mM), 1% penicillin-strep-
tomycin-neomycin antibiotic mixture (PSN, Invitrogen, Carlsbad, CA), and glucose (25 mM). Cells were 
plated at a density of 105 cells on 20-mm coverslips (for immunocytochemical studies) and 106 cells/well 
on 35-mm six-well plates (for Western blot studies), precoated with poly-L-lysine (0.1 mg/ml; Sigma). 
Twenty-four hours later, the culture medium was replaced with a mixture of 96.5% Neurobasal medium 
(Invitrogen), 2% B-27 (Invitrogen), 0.5% glutamine (2 mM), and 1% PSN. After 72 h, this medium was 
replaced with a glutamine-free version of the same medium, and the cells were grown for 10 more days 
before carrying-out experiments.
HSV-1 infection. Infection was performed as previously described5. Fourteen days after plating, the 
culture medium was replaced with Neurobasal medium containing particles of HSV-1 strain F [5 × 108 
plaque forming units (PFU)/mL] at a multiplicity of infection (MOI) of 5, and neuronal cultures were 
incubated for 1 h at 37 °C (adsorption period). The HSV-1-containing medium was then removed and 
after 2 washes in PBS, the cells were returned to the original medium and cultured for 18–24 h in the 
presence or not of specific inhibitors left in the culture medium for all the time p.i. and then fixed in 
paraformaldehyde (PFA, 4% in PBS, Sigma). The supernatants of infected cells were then subjected to 
standard plaque assay58 to quantify virus production.
In all the experiments, the effects observed in infected cells were compared with those obtained 
in mock-infected controls that had been exposed to the vehicle alone. Additional control experiments 
were performed with virus that had been exposed on ice for 5 min to a 30 W, 254 nm, germicidal UV 
light placed at a distance of 15 cm (UV-inactivated HSV-1). UV-inactivated HSV-1 retains the capacity 
for plasma membrane binding and cell entry although it is incapable of replication5, as confirmed by 
standard plaque assay.
Immunocytochemistry. Immunocytochemistry was performed as previously described5,26. Cortical 
neurons cultured for 15 DIV were infected with HSV-1 and then fixed with 4% PFA in PBS for 15 min 
at RT. After being permeabilized (10 min incubation with 0.3% Triton X-100 [Sigma] in PBS), the cells 
were incubated for 20 min with 0.3% bovine serum albumin in PBS to block nonspecific binding sites and 
then overnight at 4 °C with different pairs of the following antibodies: rabbit anti-APP phosphorylated 
at Thr668 (pAPP, 1:100; Cell Signalling Technology Inc., Danvers, MA); mouse anti-microtubule asso-
ciated protein-2 (MAP2, 1:500; Immunological Sciences, Rome, Italy), rabbit anti-pGSK3 α /β (Tyr279/
Tyr216) (1:300; Signalway Antibody, College Park, MD); rabbit anti-GSK-3β (1:300; Cell Signaling); 
goat anti-HSV-1 (1:500; Millipore); rabbit anti-Aβ 42 C-terminus (1:300; Covance, Princeton, NJ); rabbit 
anti-Aβ 40/42 AB5076 (1:300; Millipore); mouse anti-4G8 (1:300; Covance); rabbit anti-synaptophysin 
(1:300; Immunological Sciences); rabbit anti synapsin-1 XP (1:300; Cell Signaling); rabbit anti-CREB 
phosphorylated at Ser129 (1:500; Immunological Sciences); rabbit anti-CREB phosphorylated at Ser133 
(1:500; Cell Signaling). The next day, cells were incubated for 90 min at RT with a mixture of the fol-
lowing secondary antibodies: Alexa Fluor 488 donkey anti-rabbit (1:1,000; Invitrogen); Alexa Fluor 633 
donkey anti-goat (1:1,000; Invitrogen); Alexa Fluor 546 donkey anti-mouse (1:1,000; Invitrogen) Finally, 
nuclei were counterstained with 4′ ,6-diamidino-2-phenylindole (DAPI, 0.5 μ g/ml for 10 min; Invitrogen), 
and the cells were coverslipped with ProLong Gold anti-fade reagent (Invitrogen).
Images (512 × 512 pixels) were acquired at 63 ×  magnification with a confocal laser scanning system 
(TCS-SP2, Leica Microsystem, Wetzlar, Germany) and an oil-immersion objective (N.A. 1.4; physical 
pixel size: 233 nm). For some images, additional 2 ×  magnification was applied. Fluorescent dyes were 
excited with Ar/ArKr laser (for 488 nm) or HeNe lasers (for 543 and 633 nm). DAPI staining was imaged 
after two-photon excitation with an ultrafast, tunable, mode-locked titanium:sapphire laser (Chamaleon, 
Coherent Inc., Santa Clara, CA). All experiments were repeated at least 3 times, and at least 10 randomly 
chosen microscopic fields were analyzed for each condition. Immunoreactivity for pGSK3α /β , pAPP, 
Aβ 42-C-terminus, 4G8 and pCREB was quantified by drawing regions of interest (ROIs) in the acquired 
field and expressing fluorescence as the sum of intensities (8-bit depth; 256 levels) measured for every 
www.nature.com/scientificreports/
1 2Scientific RepoRts | 5:15444 | DOi: 10.1038/srep15444
pixel in the ROI. Immunofluorescence for synaptophysin and synapsin-1 were quantified as “density” 
that is the total fluorescence intensity of synaptophysin/synapsin-1 labeling (quantified as above) divided 
by the total area in the field that was occupied by neurons (identified by MAP2 immunoreactivity and 
calculated by ImageJ software [available at http://rsbweb.nih.gov/ij/]). In every studied condition, neg-
ative controls were obtained by omitting the primary antibody. The operator was blinded to the study 
conditions.
Western Blot. Infected or mock-infected mouse cortical neurons (12-15 DIV) were washed twice 
with PBS and scraped in cold RIPA buffer containing 1 mM phenylmethylsulfonyl fluoride, phosphatase 
and protease inhibitor mixtures (Sigma), and 0,1% sodium dodecyl sulfate. After incubation for 30 min 
on ice, cellular suspensions were centrifuged (10,000 × g for 30 min at 4 °C) and the supernatants were 
collected and assayed to determine their protein concentration (Micro BCA protein assay, Thermo Fisher 
Scientific, Waltham, MA). Equivalent amounts of proteins were loaded onto either 8% tris-glycine pol-
yacrylamide gels or 10–20% Novex Tricine precast gels (Invitrogen) for electrophoretic separation, and 
then electroblotted onto nitrocellulose membranes for Western blot analysis. Membranes were blocked 
with 5% nonfat dry milk in tris-buffered saline containing 0.1% Tween-20 for 1 h at RT and incubated 
with primary antibodies (rabbit polyclonal anti-GSK-3β , Cell Signaling; rabbit polyclonal anti-pGSK3 
α /β [Tyr279/Tyr216], Signalway antibody; rabbit polyclonal anti-pGSK3 α β [Ser9] Cell Signaling; rab-
bit polyclonal anti APP, Cell Signaling; rabbit polyclonal anti pAPP [Thr668], Cell Signaling; rabbit 
polyclonal anti synapsin-1 XP, Cell Signaling; mouse monoclonal anti synapthophysin, Immunological 
Science; mouse monoclonal anti Beta-Amyloid, 17–24 [4G8], Covance; mouse monoclonal anti-α Tubulin, 
Sigma; mouse monoclonal anti-GAPDH, Abcam) at a final concentration of 1 μ g/mL. After incubation 
with appropriate secondary horseradish peroxidase-conjugated antibodies (1:2,000; Cell Signaling), vis-
ualization was performed with ECL plus (GE Healthcare, Amersham Place, Buckinghamshire) using 
either UVItec Cambridge Alliance or Kodak X-OMAT films. In the latter case,images of the blots were 
acquired using a high-resolution scanner. When necessary, membranes were stripped by heating at 56 °C 
in 62.5 mM Tris-HCl, pH 6.7, with 100 mM 2-mercaptoethanol and 2% SDS and re-probed. Molecular 
weights for immunoblot analysis were determined using BenchMark™ Pre-Stained Protein Ladder 
(Invitrogen). Densitometric analysis was carried out with Image J software. Experiments were repeated 
at least 3 times.
Electrophysiological measurements in autaptic microcultures. Autaptic cultures of cortical 
neurons were prepared as previously described23,24. Glass coverslips coated with agarose, which does 
not allow cell growth, were sprayed with a mixture of poly-D-lysine and collagen (both from Sigma) 
to create microislands where glial cells could be grown. Cortical astrocytes from the brains of postnatal 
day 0-to-2 C57/Bl6 mice were cultured according to standard procedure. Dissociated cells (suspended 
in Dulbecco’s MEM supplemented with 10% fetal bovine serum and antibiotics) were plated onto the 
coverslips. After 4–6 days, when glial microislands had formed, half the medium volume was replaced 
with neuronal medium (consisting of Neurobasal medium, 2% B-27, 0.5% glutamine, and 1% PSN). 
Cortical neurons from postnatal day 0-to-2 C57/Bl6 mouse brains were prepared according to standard 
procedure5 and suspended in neuronal medium. Neurons were then plated onto glial microislands at 
low density (25 × 103/cm2) to obtain a ratio of one neuron per island. Every 4 days half the neuronal 
medium volume was replaced with fresh neuronal medium supplemented with 2 μ M cytosine arabino-
side. Autapses were studied from 9 to 21 DIV.
Synaptic transmission was studied using the patch-clamp technique in the whole-cell configuration 
as previously described24,59,60. An Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA) was 
used, and stimulation and data acquisition were performed with the Digidata 1200 series interface and 
pCLAMP 10 software (Molecular Devices). Recording electrodes were fabricated from borosilicate glass 
capillaries with the aid of a micropipette puller (P-97, Sutter Instruments, Novato, CA). The extracellular 
solution (pH 7.4) contained (in mM): 140 NaCl; 2 KCl; 10 HEPES; 10 glucose; 4 MgCl2; and 4 CaCl2. 
The internal solution (pH 7.4) contained (in mM): 136 KCl, 17.8 HEPES, 1 EGTA, 0.6 MgCl2, 4 ATP, 0.3 
GTP, 12 creatine phosphate, and 50 U/ml phosphocreatine kinase. Neurons were voltage-clamped at a 
membrane potential of − 70 mV, and stimuli mimicking action potentials (2 ms at 0 mV) were delivered 
to evoke EPSCs, which were recorded every 6 or 20 s. Input resistance, access resistance, and membrane 
capacity were monitored before and at the end of the experiments to ensure recording stability and the 
health of studied cells. The amplitudes and frequency of spontaneous mEPSCs were evaluated in 60-s 
recordings. The detection threshold was set to 3.5 times the baseline standard deviation.
Statistics. Statistical comparisons were performed with Systat 10.2 software. All data were expressed 
as mean ± standard error of the mean (SEM) and followed normal distribution, as assessed by the same 
software. In order to asses whether HSV-1 infection significantly affected the measured parameters, the 
two-tailed Student’s t test was used. One-way ANOVA with Bonferroni’s post-hoc test was used for 
multiple-comparisons. For experiments that included fewer than 10 observations (e.g. densitometric 
analysis of WB data), the Mann-Whitney (Wilcoxon) statistic was used. The level of significance was 
set at 0.05.
www.nature.com/scientificreports/
13Scientific RepoRts | 5:15444 | DOi: 10.1038/srep15444
Ethics Statement. All methods were carried out in accordance with the guidelines approved by the 
Ethics Committee of the Catholic University. All experimental and animal procedures were fully com-
pliant with Italian (Ministry of Health guidelines, Legislative Decree No. 116/1992) and European Union 
(Directive No. 86/609/EEC) legislation on animal research. Efforts were made to limit the number of 
animals used and to minimize their suffering.
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